Patient Education
EMERALD-3 Brings New Hope for People with Unresectable Liver Cancer
New results from the Phase III EMERALD-3 study offer encouraging news for people with unresectable liver cancer. By combining immunotherapy, target...
Structured Exercise Helps Colon Cancer Patients Live Longer While Lowering Healthcare Costs
The American Society of Clinical Oncology (ASCO) Annual Meeting continues to be one of the most important events for cancer research, bringing toge...
New Hope in Pancreatic Cancer Treatment: Updated Results from the RASolute 302 Trial
Pancreatic cancer remains one of the most challenging cancers to treat. In most cases, it is diagnosed at an advanced stage and is initially treate...
New Targeted Pill Shows Promise for Advanced Pancreatic Cancer
A new targeted treatment for advanced pancreatic cancer has shown encouraging early results in a major clinical trial. The experimental pill, darax...
POLAR Trial Offers New Hope for Some Patients With Metastatic Pancreatic Cancer
Early findings from the Phase 2 POLAR trial suggest that combining pembrolizumab and olaparib may benefit selected patients with metastatic pancrea...
PICCOS Clinical Trial Explores Innovative Treatment for Peritoneal Cancer
The PICCOS clinical trial is exploring an innovative chemotherapy approach called PIPAC for people with peritoneal cancer. Researchers hope this ta...
When Life Suddenly Changes: A New Guide for Young Adults Facing Digestive Cancer
DiCE launches When Life Turns to the In-Between, a new patient-led booklet supporting young adults facing digestive cancers. Covering fertility, in...
Europe’s Beating Cancer Plan: The Real Failure Is Implementation
On 14 April 2026, MEP Vlad Voiculescu (Renew, Romania) presented his report on the implementation of Europe’s Beating Cancer Plan in the European...
Switching Off KRAS: A Promising Breakthrough in Pancreatic Cancer Treatment
Results from the RASolute 302 phase 3 trial show the targeted drug Daraxonrasib improves survival in metastatic pancreatic cancer after prior treat...
Landmark New England Journal of Medicine (NEJM) Publication Advances Gastric Cancer Prevention
A new New England Journal of Medicine paper, led by International Agency for Research on Cancer, outlines practical guidance for Helicobacter pylor...